2m 2m 2m 2m 2m 2m 2m
MAR LFSCI HLDG-A (MRVI)
NASDAQ
$6.41+$0.05 (+0.79%)
Price as of Jul 13, 2026 7:24 PM EDT- $898.3MMarket Cap
- 138.20%1-Year Change
- BiotechnologyIndustry
MAR LFSCI HLDG-A (MRVI)
$6.41+$0.05 (+0.79%)
MRVI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.36 | ||
Change | +$0.27 (+4.43%) | ||
Open | $6.00 | ||
High | $6.41 | ||
Low | $6.00 | ||
Previous Close | $6.09 | ||
Volume | 3,145,942 | ||
30-Day Average Volume | 3,230,853 | ||
1-Week Change | 7.80% | ||
1-Month Change | 27.71% | ||
1-Year Change | 138.20% | ||
3-Year Change | -50.51% | ||
5-Year Change | -83.24% | ||
Fundamentals | |||
Shares Outstanding | 147.5M | ||
Total Assets | $713.2M | ||
Market Cap | $898.3M | ||
Enterprise Value | $973.4M | ||
Period: QTR TTM FY | |||
Revenue | $65.8M | ||
Net Income | -$3.7M | ||
Free Cash Flow | $4.2M | ||
EBIT | -$3.9M | ||
EBITDA | $2.6M | ||
Net Working Capital | $209.1M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | 376 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 4 | ||
P/E | -305 | ||
PEG | -3 | ||
Price/Free Cash Flow | 212 | ||
Price/Operating Cash Flow | 104 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue